Track topics on Twitter Track topics that are important to you
KYOTO, Japan, July 22, 2015 (GLOBE NEWSWIRE) -- Nidec Corporation (NYSE:NJ) today announced its consolidated results under U.S. GAAP for the period of April 1, 2015 through June 30, 2015.
The highlights are as follows:
|Selected Consolidated Results of Operations (Unaudited)|
|Yen in millions except for per share amounts and percentages||
Three months ended
March 31, 2015
|Ratio of operating income to net sales||10.9%||10.4%||--||10.8%|
|Income before income taxes||32,705||24,454||33.7||107,371|
|Ratio of income before income taxes to net sales||11.5%||10.2%||--||10.4%|
|Net income attributable to Nidec Corporation||24,196||17,573||37.7||76,216|
|Ratio of net income attributable to Nidec Corporation to net sales||8.5%||7.3%||--||7.4%|
|Net income attributable to Nidec Corporation shareholders per share-basic||81.99||63.72||--||--|
|Net income attributable to Nidec Corporation shareholders per share-diluted||81.08||59.76||--||--|
Full copy of Nidec's financial statements for the first quarter ended June 30, 2015:
A conference call webcast (audio-only, user-control slides attached) discussing Nidec's financial results for the fiscal first quarter ended June 30, 2015 is scheduled for 09:00 a.m. EDT on Wednesday, July 22, 2015. To listen to the webcast, please visit Nidec website at:
About Nidec Corporation
Nidec Corporation (NYSE:NJ) (Tokyo:6594) is a global leader in electric motor drive technology. For the first quarter ended June 30, 2015, 36.5% of its consolidated sales were represented by small precision motors; 25.0% by appliance, commercial and industrial products; 23.2% by automotive products; 9.4% by machinery; 5.6% by electronic and optical components, and 0.4% by the remaining products lines. Nidec was founded in Kyoto, Japan in 1973 by Shigenobu Nagamori, its current President and CEO.
CONTACT: Masahiro Nagayasu General Manager Investor Relations +81-75-935-6140 email@example.comNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...